Windows 10 to soon run mobile apps built for Android
by IANS
Updated Nov 29, 2020
The developers will need to package their Android apps as MSIX format and submit those to the Microsoft Store, reports Windows Central.
MSIXis a Windows app package format that provides a modern packaging experience to all Windows apps.
Currently, users can run Android apps on their PCs via app streaming using the Your Phone' app built into Windows 10.
This functionality, however, has been limited to a handful of Samsung devices.
Project Latte will allow app developers to bring apps to Windows 10 that don't have a Windows version available.
Project Latte, however, may not support Play Services as Google doesn't allow Play Services to be installed on anything other than native Android devices and Chrome OS.
"This means that apps which require Play Services APIs will need to be updated to remove those dependencies before they can be submitted on Windows 10," the report said.
Earlier, Microsoft tried the same with a similar project codenamed Astoria which did not see the light of the day.
Project Latte is likely to be powered by the Windows Subsystem for Linux (WSL).
"Microsoft has announced that WSL will soon get support forGUI Linux applications, as well asGPU accelerationwhich should aid the performance of apps running through WSL," the report mentioned.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report